BioForce Nanosciences Holdings, Inc.
BFNH
$0.5578
-$0.0101-1.78%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 900.00 | 1.60K | 700.00 | 600.00 | 600.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 900.00 | 1.60K | 700.00 | 600.00 | 600.00 |
|
|
|||||
| Total Current Assets | 900.00 | 1.60K | 700.00 | 600.00 | 600.00 |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 900.00 | 1.60K | 700.00 | 600.00 | 600.00 |
|
|
|||||
| Total Accounts Payable | 8.80K | 6.30K | 5.40K | 10.10K | 2.60K |
| Total Accrued Expenses | 2.02M | 1.91M | 1.81M | 1.70M | 1.60M |
| Short-term Debt | 274.10K | 260.00K | 251.60K | 238.30K | 220.70K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.30M | 2.18M | 2.07M | 1.95M | 1.82M |
|
|
|||||
| Total Current Liabilities | 2.30M | 2.18M | 2.07M | 1.95M | 1.82M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 274.10K | 260.00K | 251.60K | 238.30K | 220.70K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.30M | 2.18M | 2.07M | 1.95M | 1.82M |
|
|
|||||
| Common Stock & APIC | 158.82M | 158.82M | 158.81M | 158.81M | 158.81M |
| Retained Earnings | -161.12M | -161.00M | -160.88M | -160.76M | -160.63M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -2.30M | -2.18M | -2.06M | -1.95M | -1.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.30M | -2.18M | -2.06M | -1.95M | -1.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.30M | -2.18M | -2.06M | -1.95M | -1.82M |
|
|
|||||